These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Therapy of threatened abortion with progestational hormones]. Montanari GD; Marconato A; Moscolo GF; Montagner P Minerva Ginecol; 1969 May; 21(10):683-4. PubMed ID: 5402494 [No Abstract] [Full Text] [Related]
25. [Effect of therapy in threatened abortion]. Baranovskaia FS; Kovtunova LG; Pelipenko VI Pediatr Akus Ginekol; 1971; 1():41-4. PubMed ID: 5092100 [No Abstract] [Full Text] [Related]
26. [Preventive treatment of spontaneous abortion, such as it results from the study of mechanism of contraction and relaxation of uterine muscle]. Kato K; Ishida M; Higashi Y; Nakanishi S Gynecol Prat; 1972; 23(2):89-94. PubMed ID: 4636769 [No Abstract] [Full Text] [Related]
27. [Clinical study of a new progestogen in the therapy of threatened abortion]. Surace M; Crosignani PG; Campana G Minerva Ginecol; 1967 Jun; 19(11):608-12. PubMed ID: 5611221 [No Abstract] [Full Text] [Related]
28. [Effectiveness of oxyprogesterone-capronate in threatened abortion]. Pashchenko AG Vopr Okhr Materin Det; 1968 Apr; 13(4):59-63. PubMed ID: 5703209 [No Abstract] [Full Text] [Related]
29. [Hormonal profile in threatened abortion and its treatment with HCG]. Desanso G; Lalario R; Cenderelli G; D'Addato F; Surico N; Visentin L Minerva Ginecol; 1981 May; 33(5):421-8. PubMed ID: 7254663 [No Abstract] [Full Text] [Related]
30. [The pathogenesis of diabetes insipidus in pregnancy (description of a case)]. Laghi A; Tomasillo MR Arch Ostet Ginecol; 1980; 85(4):297-305. PubMed ID: 7344669 [No Abstract] [Full Text] [Related]
31. A clinical trial and cytological assessment of enol LUTEOVIS IN THE TREATMENT OF THREATENED AND RECURRENT ABORTION. Burton ER; Wachtel EG J Obstet Gynaecol Br Commonw; 1967 Aug; 74(4):533-6. PubMed ID: 5340429 [No Abstract] [Full Text] [Related]
33. [Vitamin K in obstetrics--effects of vitamin K1 on threatened abortion and premature labor]. Hata Y Nihon Sanka Fujinka Gakkai Zasshi; 1967 Nov; 19(11):1398-401. PubMed ID: 5627227 [No Abstract] [Full Text] [Related]
34. [Study of 6-dehydro-retro-progesterone; especially in comparison with the effect of 17-alpha-ethynyl-19-nortestosterone]. Yamamoto K Zasshi Tokyo Ika Daigaku; 1968 Jul; 26(3):385-403. PubMed ID: 5750349 [No Abstract] [Full Text] [Related]
35. [Effect of turinal and progesterone combined with chorionic gonadotropin on cellular immunity during the treatment of threatened abortion in the first and second trimesters]. Zhuchenko PG; Lisovskaia TV; Gordiĭchuk VD Akush Ginekol (Mosk); 1988 Dec; (12):24-7. PubMed ID: 3266544 [No Abstract] [Full Text] [Related]
37. Physiology should be supported with evidence in progesterone administration for threatened miscarriage. Sotiriadis A; Makrydimas G Am J Reprod Immunol; 2005 Oct; 54(4):240. PubMed ID: 16135015 [No Abstract] [Full Text] [Related]
39. [Control of the effect of treatment in late threatened abortions using the DU-1 Dynamo-uterograph]. Tsenov D; Penev I; Tsankov Ts Akush Ginekol (Sofiia); 1982; 21(1):11-5. PubMed ID: 7081613 [No Abstract] [Full Text] [Related]